References
1. Integraal Kankercentrum Nederland (2020, July 7). Epitheliale
eierstokkanker. Retrieved from https://www.iknl.nl/. Epitheliale
eierstokkanker (2020).
2. Chan, J. K. et al. Association of lymphadenectomy and survival
in stage I ovarian cancer patients. Obstet. Gynecol. 109, 12–19
(2007).
3. Trimbos, B. et al. Surgical Staging and Treatment of Early
Ovarian Cancer : Long-term Analysis From a Randomized Trial. 102,
(2010).
4. Trimbos, J. B. et al. Impact of Adjuvant Chemotherapy and
Surgical Staging in Early-Stage Ovarian Carcinoma : European
Organisation for Research and Treatment of Cancer – Adjuvant
ChemoTherapy in Ovarian. 95, 113–125 (2003).
5. Prat, J. & Committee, F. International Journal of Gynecology and
Obstetrics Staging classi fi cation for cancer of the ovary , fallopian
tube , and peritoneum ☆. Int. J. Gynecol. Obstet. 1–5 (2013).
doi:10.1016/j.ijgo.2013.10.001
6. Benedet, J. L., Bender, H. & Pecorelli, S. FIGO staging
classifications and clinical practice guidelines in the management of
gynecologic cancers. (2000).
7. Cass, I. et al. Pattern of lymph node metastases in clinically
unilateral stage I invasive epithelial ovarian carcinomas.Gynecol. Oncol. 80, 56–61 (2001).
8. Powless, C. A., Bakkum-Gamez, J. N., Aletti, G. D. & Cliby, W. A.
Random peritoneal biopsies have limited value in staging of apparent
early stage epithelial ovarian cancer after thorough exploration.Gynecol. Oncol. 115, 86–89 (2009).
9. Mourad Ouzzani, Hossam Hammady, Zbys Fedorowicz, and Ahmed
Elmagarmid. Rayyan — a web and mobile app for systematic reviews.
Systematic Reviews (2016) 5:210, D. 10. 1186/s1364.-016-0384-4. Rayyan.
10. Wells, G. A., Shea, B., O’connell, D., Peterson, J., Welch, V.,
Losos, M., & Tugwell, P. (2016). T. N.-O. S. (NOS) for assessing the
quality if nonrandomized studies in meta-analyses. 2009. E. A. from: U.
http://www. ohri. ca/programs/clinical_epidemiology/oxford. htm
[cited 2020 A. 27]. No Title.
11. Mahdi, H. et al. Prevalence and prognostic impact of
lymphadenectomy and lymph node metastasis in clinically early-stage
ovarian clear cell carcinoma. Int. J. Gynecol. cancer Off. J. Int.
Gynecol. Cancer Soc. 23, 1226–1230 (2013).
12. Hengeveld, E. M., Zusterzeel, P. L. M., Lajer, H., Høgdall, C. K. &
Rosendahl, M. The value of surgical staging in patients with apparent
early-stage epithelial ovarian carcinoma. Gynecol. Oncol. 154,
308–313 (2019).
13. Padhy, R. R., Savage, J. & Kurman, R. J. Comprehensive Surgical
Staging in Stage 1 Clear Cell and Endometrioid Ovarian Carcinomas : Is
it Necessary ? 241–246 (2018). doi:10.1097/PGP.0000000000000521
14. Lee, J.-Y. et al. The role of omentectomy and random
peritoneal biopsies as part of comprehensive surgical staging in
apparent early-stage epithelial ovarian cancer. Ann. Surg. Oncol.21, 2762–2766 (2014).
15. Ditto, A. et al. Systematic para-aortic and pelvic
lymphadenectomy in early stage epithelial ovarian cancer: a prospective
study. Ann. Surg. Oncol. 19, 3849–3855 (2012).
16. Negishi, H. et al. Lymphatic mapping and sentinel node
identification as related to the primary sites of lymph node metastasis
in early stage ovarian cancer. Gynecol. Oncol. 94, 161–166
(2004).
17. Mujezinovic, F. Tumor laterality in early ovarian cancer :
influence on left-right asymmetry of pelvic. 695–698 (2010).
18. William, F. et al. Staging Laparotomy in Early Ovarian
Cancer. (2015).
19. Ayhan, A. et al. Occult metastasis in early ovarian
cancers : risk factors and. YMOB 196, 81.e1-81.e6 (2007).
20. Ayhan, A. et al. Routine appendectomy in epithelial ovarian
carcinoma: is it necessary? Obstet. Gynecol. 105, 719–724
(2005).
21. faught2003.pdf.
22. Onda, T., Yoshikawa, H., Yokota, H., Yasugi, T., & Taketani, Y.
(1996). Assessment of metastases to aortic and pelvic lymph nodes in
epithelial ovarian carcinoma: a proposal for essential sites for lymph
node biopsy. Cancer: Interdisciplinary Internationa. (1996).
23. Garcia-Soto, A. E., Boren, T., Wingo, S. N., Heffernen, T. &
Miller, D. S. Is comprehensive surgical staging needed for thorough
evaluation of early-stage ovarian carcinoma? Am. J. Obstet.
Gynecol. 206, 242.e1–5 (2012).
24. Le, T., Adolph, A., Krepart, G. V, Lotocki, R. & Heywood, M. S. The
benefits of comprehensive surgical staging in the management of
early-stage epithelial ovarian carcinoma. Gynecol. Oncol. 85,
351–355 (2002).
25. Gouy, S. et al. Gynecologic Oncology Reports Staging surgery
in early-stage ovarian mucinous tumors according to expansile and in fi
ltrative types. Gynecol. Oncol. Reports 22, 21–25 (2017).
26. Naru, R. R., Hulikal, N., Nandyal, R. & Bodagala, V. Including
Para-Aortic Lymph Node Dissection of Presumed Early Stage Epithelial
Ovarian Cancer : 33, 184–188 (2017).
27. Mueller, J. J. et al. Staging Lymphadenectomy in Patients
With Clear Cell Carcinoma of the Ovary Upstaging in Clinically Apparent.
26, 120–124 (2016).
28. Minig, L. et al. Patterns of Lymph Node Metastases in
Apparent Stage I Low-Grade Epithelial Ovarian Cancer: A Multicenter
Study. Ann. Surg. Oncol. 24, 2720–2726 (2017).
29. Bogani, G. et al. Assessing the risk of pelvic and
para-aortic nodal involvement in apparent early-stage ovarian cancer: A
predictors- and nomogram-based analyses. Gynecol. Oncol. 147,
61–65 (2017).
30. Babayeva, A. et al. Clinical Outcome After Completion Surgery
in Patients With Ovarian Cancer: The Charite Experience. Int. J.
Gynecol. cancer Off. J. Int. Gynecol. Cancer Soc. 28, 1491–1497
(2018).
31. Bachmann, C. et al. Relevance of pelvic and para-aortic node
metastases in early-stage ovarian cancer. Anticancer Res. 34,
6735–6738 (2014).
32. Bacalbasa, N. et al. The Risk of Para-Aortic Lymph Node
Metastases in Apparent Early Stage Ovarian Cancer. Medicina
(Kaunas). 56, (2020).
33. Suzuki, M. et al. Lymph node metastasis in stage I epithelial
ovarian cancer. Gynecol. Oncol. 79, 305–308 (2000).
34. Shroff, R. et al. The utility of peritoneal biopsy and
omentectomy in the upstaging of apparent early ovarian cancer.Int. J. Gynecol. cancer Off. J. Int. Gynecol. Cancer Soc. 21,
1208–1212 (2011).
35. Press, E. B. Department Accepted. 13, 303–307 (1982).
36. Schmeler, K. M. et al. Prevalence of lymph node metastasis in
primary mucinous carcinoma of the ovary. Obstet. Gynecol. 116, 269–273
(2010).
37. Matsuo, K. et al. Adequate pelvic lymphadenectomy and survival of
women with early-stage epithelial ovarian cancer. J. Gynecol. Oncol. 29,
(2018).
38. Hoogendam, J. P., Vlek, C. A., Witteveen, P. O., Verheijen, R. H. M.
& Zweemer, R. P. Surgical lymph node assessment in mucinous ovarian
carcinoma staging: a systematic review and meta-analysis. BJOG An
Int. J. Obstet. Gynaecol. 124, 370–378 (2017).
39. Baldwin, L. A. et al. Ten-year relative survival for
epithelial ovarian cancer. Obstet. Gynecol. 120, 612–618 (2012).
40. Gmyrek, L. J., Jonska-Gmyrek, J., Sobiczewski, P., Panek, G. &
Bidzinski, M. Evaluation of intraoperative and postoperative
complications related to lymphadenectomy in ovarian cancer patients.Oncol. Lett. 2, 537–541 (2011).
41. Kim, S. I. et al. Impact of lower limb lymphedema on quality
of life in gynecologic cancer survivors after pelvic lymph node
dissection. Eur. J. Obstet. Gynecol. Reprod. Biol. 192, 31–36
(2015).
42. Günakan, E. et al. Factors associated with surgical morbidity
of primary debulking in epithelial ovarian cancer. Obstet.
Gynecol. Sci. 63, 64–71 (2020).
43. Tantitamit, T. & Lee, C.-L. Is It the Time for Laparoscopic
Management of Early-stage Ovarian Malignancies? Gynecol. Minim.
invasive Ther. 7, 93–103 (2018).
44. Zeff, N. Role of laparoscopy in initial tumour staging in advanced
epithelial ovarian cancer: A systematic review. Pleura and
Peritoneum 3, (2018).
45. Melamed, A. et al. Cancer : Analysis of the National Cancer
Data Base. 216, 1–20 (2018).
46. Kleppe, M. et al. Gynecologic Oncology Lymph node metastasis
in stages I and II ovarian cancer : A review. Gynecol. Oncol.123, 610–614 (2011).